MD-reviewed ·  Healthcare editorial
MedAI Verdict
All articles

Surgical AI / Healthcare AI / Clinical AI

Best AI Surgical Tools in 2026: OR Analytics, Robotic AI, VR Training

MD-reviewed comparison of the AI surgical tools shaping operating rooms in 2026: da Vinci Case Insights, OR Black Box, Touch Surgery, Osso VR, Theator, Caresyntax and more. Enterprise capital territory.

Editorial illustration: surgical instruments with an operating-room video feed translating into performance analytics.
Illustration · Editorial
Author
Healthcare AI Hub Editorial Team
Published
May 15, 2026
Updated
May 19, 2026
Reading time
16 minutes

TL;DR (the verdict, if you have a board meeting in an hour)

This is a buyer's guide for surgical chairs, CMIOs, OR directors, and residency program directors evaluating AI in three places where it actually changes outcomes today: robotic systems, intraoperative analytics, and pre-OR training. Almost everything in this category is a capital purchase or enterprise SaaS contract. There is no consumer affiliate market here, and we don't pretend otherwise. The post exists because the buying decisions are getting harder and the vendor noise is getting louder.

Best with da Vinci robotics: Case Insights (da Vinci 5). Bundled post-case analytics from Intuitive Surgical (ISRG). If you already own da Vinci 5 systems, this is the default surgical-AI layer you turn on first.

Best whole-OR recording and safety analytics: OR Black Box. Audio, video, and physiologic capture deployed at Mayo, Mount Sinai, Duke, and roughly 40 institutions. Closest thing surgery has to an aviation flight-data recorder.

Best free mobile surgical simulator: Touch Surgery Enterprise. Medtronic's app is genuinely free for individual surgeons and residents. Enterprise tier adds video capture and analytics.

Best VR surgical training: Osso VR. Cited 230% performance-improvement study, used by orthopedic and spine residency programs across the US.

Methodology framing: we aggregated vendor documentation, ACS and AAOS guidance, KLAS-style adoption signals, peer-reviewed surgical-AI literature, and clinician sentiment from r/surgery and r/Residency. The post was signed off by our board-certified physician advisor. Full weights at [/methodology](https://healthcareai.brainbyt.es/methodology).

How we evaluated 20 AI surgical tools

We do not run hands-on operative trials. The math doesn't work for an independent editorial team, and procedure mix matters more than ours would. Our evaluation aggregates six sources, weighted the same way across the entire Healthcare AI Hub.

  1. Vendor documentation (30%): pricing pages, FDA 510(k) listings, security attestations, EHR and PACS integration disclosures.

  2. Public review aggregators (20%): G2, Capterra, KLAS-style summaries where they exist.

  3. Clinician community sentiment (20%): Reddit r/surgery, r/Residency, AAOS and ACS member forums, sentiment-scored with source URL logged.

  4. Peer-reviewed literature (15%): PubMed-indexed studies evaluating the tool in operative or training settings.

  5. Vendor stability (10%): funding rounds, parent-company strength (Intuitive, J&J, Medtronic, Microsoft), FDA clearance history.

  6. Specialty-society guidance (5%): ACS, AAOS, SAGES, AUA, and ACGME statements where published.

Surgical AI is mostly capital territory. Expect contracts in the six- to seven-figure range, multi-year service agreements, and a security and bio-medical engineering review before anything plugs into your OR network. Pricing in this category changes through negotiated quotes, not list pages. If you spot stale data, email corrections@healthcareai.brainbyt.es and we publish a correction within seven business days.

Best with da Vinci robotics: Case Insights (da Vinci 5)

Case Insights is the AI analytics layer Intuitive Surgical ships with the da Vinci 5 platform. It is the first surgical-AI product most US hospitals will touch, simply because da Vinci installed base now exceeds 9,500 systems globally and the analytics ride along the existing capital purchase. Post-case dashboards summarize energy use, instrument exchanges, port placement, console time, and procedural-step efficiency, with peer benchmarks at the surgeon and program level.

The strategic question is not whether to use it. If you own a da Vinci 5, you already have it. The question is whether your service line will operationalize it: assign a champion, review dashboards monthly at M&M, and tie variance to specific behaviors. Hospitals that treat Case Insights as a dashboard tend to ignore it. Hospitals that treat it as a structured peer-review feed tend to see meaningful reductions in console time variance within two quarters.

Pros

  • Native to da Vinci 5. No separate integration, no extra capture hardware, no security review beyond the existing Intuitive contract.

  • Surgeon-level benchmarking against the broader da Vinci dataset (de-identified).

  • Vendor stability is settled. Intuitive Surgical is publicly traded (ISRG), profitable, and the dominant robotic-surgery platform.

  • Procedure-step segmentation supports targeted coaching and OR-time forecasting.

Cons

  • Locked to da Vinci. Useless if you are evaluating J&J's Ottava, Medtronic's Hugo, or Asensus Senhance.

  • Read-only for surgeons in most deployments. No coaching workflow, no peer-review case-tagging out of the box.

  • Bundled pricing makes it hard to compare ROI against standalone surgical-intelligence platforms.

Best for: Health systems with established da Vinci programs that want surgeon variance benchmarking without standing up a third-party analytics contract.

Read the full Case Insights review →

Best whole-OR recording and safety analytics: OR Black Box

OR Black Box from Surgical Safety Technologies is the closest thing operating rooms have to the flight-data recorder model that fixed commercial aviation. The platform captures synchronized audio, video, and physiologic streams across the room, de-identifies them, and runs AI analytics for safety events, communication breakdowns, and workflow inefficiencies. As of public reporting in 2024-2025, deployments include Mayo Clinic, Mount Sinai, Duke, Stanford, and roughly 40 institutions in North America and Europe.

The aviation analogy holds up. The system was originally developed by Dr. Teodor Grantcharov at the University of Toronto, modeled explicitly on flight recorders. Its strongest case is the one most hospitals don't want to talk about: a recorded, de-identified record that supports quality improvement rather than disciplinary review, with contractual and ethical guardrails to keep it on the QI side of the legal line. That governance question is usually the gating factor, not the technology.

Pros

  • Whole-room capture: cameras, microphones, anesthesia data, devices. Not just laparoscopic feed.

  • AI tagging of safety events, distractions, and communication patterns flagged for review.

  • Strong academic-center adoption gives multi-year peer-reviewed evidence base, including studies in Annals of Surgery and JAMA Surgery.

  • Governance frameworks battle-tested with hospital legal teams (Mayo, Mount Sinai publish on their model).

Cons

  • Heavy install. Cameras and microphones across each OR, plus storage and review infrastructure.

  • Governance and union conversations are non-trivial. Plan a six- to twelve-month change-management runway.

  • Pricing is bespoke per-OR contract, no published list.

Best for: Academic medical centers and large systems running a serious surgical-quality program, with legal and labor counsel ready to scope a QI-protected deployment.

Read the full OR Black Box review →

Best free mobile surgical simulator: Touch Surgery Enterprise

Touch Surgery Enterprise is the Medtronic Digital Surgery product line, evolved from the original Touch Surgery app that has shipped tens of millions of procedure simulations on iOS and Android. The consumer app is still free. Individual surgeons and residents can use the mobile simulator and step-through library without an institutional contract, which makes it the easiest surgical-AI tool to put in the hands of trainees this week.

The Enterprise tier is the part that matters at the OR level. It adds AI-driven surgical video capture, automatic case-segmentation, and a video review workflow attached to Medtronic's broader digital surgery platform. The reason it stays on this list is the combination of free mobile access for trainees, a clear upgrade path to enterprise video analytics, and Medtronic's distribution muscle to deploy across a multi-site GI or general-surgery service line.

Pros

  • Free mobile app with 200+ procedure simulations covering general surgery, ortho, ENT, OB-GYN, and more.

  • Enterprise tier adds AI video capture and case-segmentation analytics tied to Medtronic devices.

  • Medtronic-level vendor stability and global service footprint.

  • Lightest possible onramp for residency programs: download, log in, start simulating.

Cons

  • The free mobile experience and enterprise platform are functionally different products bundled under one brand.

  • Enterprise integrations are strongest in Medtronic-equipped ORs; less compelling if you are an Intuitive- or J&J-heavy system.

  • Public case-quality evidence is thinner than for Osso VR or PrecisionOS.

Best for: Residency programs that want a free, low-friction simulator across the entire program, and Medtronic-aligned systems that want OR video analytics from the same vendor.

Read the full Touch Surgery review →

Best VR surgical training: Osso VR

Osso VR is the VR surgical training platform most US orthopedic and spine residency programs evaluate first. The vendor's most-cited study, published in JAMA Network Open and replicated in subsequent ortho trials, reported a 230% improvement in overall surgical performance among VR-trained learners versus standard prep. Even discounting the headline number for the usual sponsor-funded caveats, the underlying signal of structured VR rehearsal beating reading and observation is consistent across the surgical-education literature.

Osso ships an enterprise institutional license with a content library covering orthopedic, spine, cardiovascular, and general surgery procedures, plus haptic-aware scoring on a Meta Quest deployment. Procurement is straightforward by VR-training standards: headsets, an institutional license, and a content selection aligned to your residency's case mix. The catch is that the technology rewards programs that build it into the curriculum, not programs that buy headsets and leave them on a shelf.

Pros

  • Strongest published evidence base in VR surgical training (JAMA Network Open and follow-on studies).

  • Broad content library across ortho, spine, cardio, general surgery.

  • Standardized AI performance scoring supports objective resident assessment for ACGME milestones.

  • Meta Quest deployment keeps hardware cost low relative to PrecisionOS-class haptic rigs.

Cons

  • Requires curriculum integration. Headsets without a structured rotation deliver mediocre outcomes.

  • Procedure library skews ortho and spine; general-surgery content less deep than Touch Surgery.

  • Enterprise pricing only. No individual-resident subscription tier.

Best for: Orthopedic, spine, and procedural residency programs that will commit a faculty champion to integrate VR into the rotation schedule.

Read the full Osso VR review →

What to look for: 5-criteria buyer's guide

Criterion 1: Robotic platform alignment

Surgical AI is locked to specific hardware more than any other category in healthcare. If your system runs da Vinci, Case Insights is essentially the default and you should weigh third-party analytics against it. If your system has committed to J&J Digital Surgery (the platform formerly known as Verb Surgical, now anchored on J&J's Ottava robot and Polyphonic ecosystem) or Medtronic's Hugo, the analytics partner is usually pre-decided by the OEM relationship. Treat the OEM choice as the upstream decision and the AI layer as downstream.

Criterion 2: FDA clearance and evidence base

The category includes everything from FDA-cleared real-time visualization (Activ Surgical holds 510(k) clearance on ActivSight) to non-cleared simulation and analytics products that legitimately don't need clearance. The bar to apply is matching claim to clearance. A tool claiming intraoperative decision support is in a different regulatory bucket than a tool claiming post-case quality benchmarking. Read the actual 510(k) summary, not the marketing page. ACS and SAGES are increasingly publishing guidance on appropriate use cases for AI in surgery; cross-check against those.

Criterion 3: Workflow integration and capture surface

Whole-OR platforms like OR Black Box and Caresyntax require physical install, network access, and de-identification pipelines. Video-only platforms like Theator and C-SATS capture from the laparoscopic or robotic feed only, which means lighter install but narrower data. Tele-collaboration platforms like Proximie sit somewhere in between, capturing case video and streaming for remote scrubbing or proctoring. Match the capture surface to the question you want answered.

Criterion 4: Governance, legal, and labor

This is the single most underestimated cost in surgical-AI deployment. Recording an OR triggers conversations with hospital counsel, peer-review-protection statutes (which vary by state), nursing union contracts, and, in academic centers, the IRB. Mature deployments at Mayo, Mount Sinai, and Duke published governance models specifically because the legal scaffolding took longer than the install. Budget six to twelve months for change management on whole-OR capture. The vendors who help you draft the QI-protection framework are worth more than the vendors who ship slightly better dashboards.

Criterion 5: Vendor stability

Surgical AI is consolidating fast. The acquisitions matter: Brainlab acquired Level Ex, Medtronic owns Digital Surgery, J&J consolidated Verb Surgical into J&J Digital Surgery and Auris Health. The startups still standing in 2026 (Theator, Caresyntax, Proximie, Activ Surgical, Osso VR, FundamentalVR, PrecisionOS) all carry residual acquisition risk. That is fine; just price the risk into a multi-year contract by negotiating data-export and continuity clauses up front. If the analytics vendor is acquired, you want your case data, your dashboards, and your model outputs to come with you.

How the field has shifted in 2026

Three things changed since 2024 worth flagging. First, da Vinci 5 shipped with Case Insights bundled, which moved the default robotic-AI layer from third-party to OEM. Standalone analytics vendors had to sharpen their wedge against that default, and most repositioned toward platform-agnostic OR video and safety capture rather than robotic-procedure analytics specifically. Second, J&J retired the Verb Surgical brand and consolidated everything under J&J Digital Surgery anchored on Ottava and the Polyphonic ecosystem, which made the J&J pitch easier to evaluate against Intuitive. Third, the ACS and AAOS began publishing more pointed guidance on AI use in surgical training and OR analytics, including the boundaries around recorded video and resident assessment. The compliance side of this category got more, not less, complicated. Expect more guidance from CMS and TJC over the next 18 months.

Comparison table

Full side-by-side comparison: see the complete tool table.

Frequently asked questions

Which AI surgical tool should we evaluate first if we already own da Vinci systems?

Turn on Case Insights first; it is bundled with da Vinci 5 and surfaces post-case analytics with no additional integration. Only after you have one to two quarters of dashboard data should you evaluate a third-party platform like Theator or Caresyntax to complement what the OEM layer doesn't cover, typically multi-platform analytics or outcomes correlation.

Is OR Black Box admissible in malpractice litigation?

In most US jurisdictions, properly structured QI deployments fall under peer-review protection, which limits discoverability. The deployments at Mayo, Mount Sinai, and Duke explicitly run under QI frameworks with legal and labor counsel. State law varies. Get your hospital counsel involved before signing. The vendors with mature governance playbooks (Surgical Safety Technologies for OR Black Box, Caresyntax) are easier to deploy than vendors who hand you the legal problem.

Does VR surgical training actually transfer to OR performance?

The peer-reviewed evidence keeps growing. The most-cited Osso VR study reported a 230% improvement in performance metrics among VR-trained learners, published in JAMA Network Open. Follow-up ortho trials show similar directional results when programs commit to structured curriculum integration. The honest caveat is that VR alone, without curriculum integration and faculty review, produces underwhelming results. The technology is necessary, not sufficient.

What is J&J Digital Surgery and why does it keep coming up?

J&J Digital Surgery is J&J MedTech's consolidated digital and robotic surgery stack, anchored on the Ottava robotic system and the Polyphonic ecosystem. It absorbed and retired the Verb Surgical brand (J&J's joint venture with Alphabet's Verily, dissolved in 2023) and Auris Health. If you are evaluating a non-Intuitive robotic future, J&J is the most serious alternative to Intuitive and Medtronic.

What's the realistic budget for a meaningful surgical AI deployment in 2026?

Floor: roughly $100,000 to $200,000 for a focused VR-training program with PrecisionOS or Osso VR across a single residency. Mid: $500,000 to $1.5M annually for an OR-intelligence rollout with Caresyntax or OR Black Box across 8 to 12 ORs. Ceiling: $2M+ in capital per da Vinci 5 system, with analytics bundled. Anything below the floor is a pilot, not a program.

Related reading on Healthcare AI Hub

Methodology + disclosure

This article aggregates vendor documentation, public clinical-use evidence, peer-reviewed surgical-AI literature, ACS and AAOS guidance, and clinician sentiment from r/surgery and r/Residency, signed off by our board-certified physician advisor. Surgical AI is overwhelmingly an enterprise capital category. We do not run affiliate programs for any tool covered in this post and we receive no commission on enterprise contracts. We exist as a topical-authority reference for the buying conversations our readers are already having. Full policy at /affiliate-disclosure.